Sunshine Biopharma, Inc.
SBFM
$1.05
$0.021.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.97% | -9.69% | 25.75% | -15.40% | -20.65% |
| Total Receivables | -16.74% | 15.83% | 4.13% | -10.94% | 20.19% |
| Inventory | -4.21% | 8.03% | 9.80% | 5.13% | 14.84% |
| Prepaid Expenses | 80.84% | -53.00% | -4.48% | -13.22% | 54.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.98% | 0.42% | 13.77% | -5.72% | -0.06% |
|
|
|||||
| Total Current Assets | -3.98% | 0.42% | 13.77% | -5.72% | -0.06% |
| Net Property, Plant & Equipment | -5.81% | -7.35% | 7.78% | -4.14% | 30.89% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.97% | -19.33% | -22.00% | 5.75% | 2.62% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Assets | -4.47% | -1.50% | 9.52% | -4.49% | 1.68% |
|
|
|||||
| Total Accounts Payable | -7.71% | 27.93% | -4.52% | -9.36% | 33.33% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.15% | -1.98% | 3.97% | 2.98% | 78.68% |
| Total Finance Division Other Current Liabilities | 90.70% | -46.61% | 5.75% | -7.13% | 121.22% |
| Total Other Current Liabilities | 90.70% | -46.61% | 5.75% | -7.13% | 121.22% |
| Total Current Liabilities | -3.12% | 19.33% | -3.27% | -8.75% | 39.45% |
|
|
|||||
| Total Current Liabilities | -3.12% | 19.33% | -3.27% | -8.75% | 39.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.27% | -9.88% | -2.17% | -3.02% | 69.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.39% | 16.04% | -3.15% | -8.14% | 40.70% |
|
|
|||||
| Common Stock & APIC | 0.74% | 0.00% | 3.91% | 0.38% | 1.76% |
| Retained Earnings | -2.94% | -1.23% | -2.52% | -1.71% | -3.23% |
| Treasury Stock & Other | 79.64% | -214.25% | 134.93% | 3.16% | -592.29% |
| Total Common Equity | -4.80% | -5.79% | 13.14% | -3.40% | -6.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -4.80% | -5.79% | 13.14% | -3.40% | -6.15% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.80% | -5.78% | 13.14% | -3.40% | -6.14% |
|
|
|||||